Rituximab plus chemotherapy as first-line treatment in Chinese patients with diffuse large B-cell lymphoma in routine practice: a prospective, multicentre, non-interventional study.
Wu J, Song Y, Su L, Xu L, Chen T, Zhao Z, Zhang M, Li W, Hu Y, Zhang X, Gao Y, Niu Z, Feng R, Wang W, Peng J, Li X, Ouyang X, Wu C, Zhang W, Zeng Y, Xiao Z, Liang Y, Zhuang Y, Wang J, Sun Z, Bai H, Cui T, Feng J.
Wu J, et al. Among authors: li w, li x.
BMC Cancer. 2016 Jul 26;16:537. doi: 10.1186/s12885-016-2523-7.
BMC Cancer. 2016.
PMID: 27460571
Free PMC article.
Clinical Trial.